Detect the disrupted brain structural connectivity in type 2 diabetes mellitus patients without cognitive impairment

Table 1 Demographics and clinical data of type 2 diabetes mellitus and healthy controls

	T2DM subjects, (n = 47)	Healthy controls, (n = 47)	P value
Demographics
Age (years)	57.36 ± 8.04	55.62 ± 8.36	0.305
Gender (male/female)	18/29	25/22	0.147
Clinical data
BMI (kg/m2)	24.52 ± 2.09	20.78 ± 1.40	0.0001
SBP (mmHg)	124.15 ± 9.66	114.51 ± 6.67	0.0001
DBP (mmHg)	75.62 ± 6.54	70.36 ± 5.14	0.0001
HbA1c (%)	8.03 ± 1.53	N/A	N/A
FBG (mmol/L)	6.73 ± 2.15	N/A	N/A
TG (mmol/L)	1.65 ± 0.42	N/A	N/A
TC (mmol/L)	4.93 ± 1.03	N/A	N/A
HDL (mmol/L)	1.00 ± 0.20	N/A	N/A
LDL (mmol/L)	2.59 ± 0.53	N/A	N/A
Course of disease (years)	6.60 ± 3.41	N/A	N/A

¹P < 0.05.

Values distributed normally or non-normally are presented as mean ± SD or median (minimum, maximum). HbA1c: Hemoglobin A1C; BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; FBG: Fasting blood glucose; TG: Triglyceride; TC: Total cholesterol; LDL: Low density lipoprotein; NA: Not Applicable.